Services do NOT include
Please contact the service provider to discuss your study outline.
Summary of results.
Sample Requirements - input of users
Various. To be discussed before starting.
Dr. Thomas Courant
Adjuvant and formulation services
Description of service
Users can ship their Sars-Cov2 vaccine antigens to the Vaccine Formulation Institute (VFI) for formulation with VFI adjuvants. Among these adjuvants, a squalene oil-in-water emulsion and a liposome-based formulation containing QS21 are on track to be available at clinical-grade in the context of the development of vaccines against Covid-19. Users can also request a specific adjuvant to be included in the formulation studies.
Once optimal formulations are identified (including physico-chemical characteristics of the adjuvanted vaccine candidate), VFI can perform immunogenicity studies in mice including analyses of B- and T-cell responses.
A brief report of the study results will be provided to the User.
Project duration approximately 2 months
Dr. Maria Lawrenz